Anesthetic drugs for the treatment of status epilepticus

Epilepsia
Sara Hocker

Abstract

Worsening pharmacoresistance to antiseizure drugs is common with ongoing excitotoxic neuronal and systemic injury. Early initiation of anesthetic drugs in refractory status epilepticus (RSE) may halt these processes while allowing time for treatment targeting the cause of the seizures. Current guidelines support the use of anesthetic drugs as the third line pharmacologic therapy in generalized convulsive status epilepticus but do not clearly define the indications for these drugs in other types of status epilepticus. There is wide practice variation in choice of third line therapy for RSE, but there is overall consensus that anesthetics should be initiated earlier in generalized convulsive status epilepticus than in nonconvulsive forms. More recently, doubt has been cast on the appropriateness of anesthetic treatment of RSE following a series of studies associating their use with higher mortality and morbidity. This suggests that efforts should focus on determination of who benefits most, optimal use, and prevention of refractoriness. The risk-benefit ratio of anesthetic use is discussed, with specific indications proposed. In addition, anesthetic dosing, supportive neurocritical care, electroencephalogram suppression target, a...Continue Reading

References

Jul 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·O C CockerellS D Shorvon
Sep 9, 1999·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·P W Kaplan
Feb 15, 2002·Archives of Neurology·Stephan A MayerBrian-Fred Fitzsimmons
May 28, 2003·Journal of the Neurological Sciences·Jan ClaassenStephan A Mayer
Mar 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·M HoltkampH Meierkord
Nov 16, 2005·Archives of Neurology·Andrea O RossettiEdward B Bromfield
Aug 8, 2009·Critical Care Medicine·Vivek N IyerAlejandro A Rabinstein
Jan 7, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H MeierkordUNKNOWN European Federation of Neurological Societies
Apr 25, 2012·Neurocritical Care·Gretchen M BrophyUNKNOWN Neurocritical Care Society Status Epilepticus Guideline Writing Committee
Oct 26, 2012·Neurocritical Care·James J RivielloUNKNOWN Neurocritical Care Society Status Epilepticus Guideline Writing Committee
Jan 16, 2013·JAMA Neurology·Sara E HockerAlejandro A Rabinstein
Feb 13, 2014·Neurocritical Care·Bhavpreet S DhamFred Rincon
Jun 3, 2014·Critical Care : the Official Journal of the Critical Care Forum·Deborah PuginJan Claassen
Aug 27, 2014·Neurology·Sara E Hocker, Simon Shorvon
Feb 6, 2015·Critical Care Medicine·Nicola A MarchiAndrea O Rossetti
May 9, 2015·Epilepsy & Behavior : E&B·M FerlisiUNKNOWN International Steering Committee of the StEp Audit
May 15, 2015·Epilepsy & Behavior : E&B·Sara Hocker

❮ Previous
Next ❯

Citations

Sep 6, 2020·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Edilberto AmorimM Brandon Westover

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revista de neurologia
N Torres-CanoJ Moliner-Ibanez
Anales de medicina interna : organo oficial de la Sociedad Española de Medicina Interna
J Fermoso García
© 2022 Meta ULC. All rights reserved